Supply Chain

GDP-Compliant Pharmaceutical Supply Chain & Logistics

NovaPharm Healthcare operates an end-to-end regulatory-first supply chain — from EU-GMP supplier qualification and MHRA PLPI regulatory filing through to cold-chain distribution, last-mile delivery, and active pharmacovigilance. Every step is documented, auditable, and fully GDP-compliant.

How It Works

Regulatory-First End-to-End Process

Our supply chain is built around regulatory compliance at every stage — ensuring that every product we distribute meets the highest standards of quality, safety, and traceability before it reaches a patient.

Supplier Qualification & Audit

Every supplier undergoes a structured qualification process before entering our network.

  • EU-GMP certification verification
  • On-site or remote GDP compliance audit
  • Quality Certificate and manufacturing record review
  • Ongoing supplier performance monitoring

Batch Documentation & CoA

All products are fully documented before they move in the supply chain.

  • Certificate of Analysis (CoA) secured per batch
  • Quality Overall Summary (QOS) review
  • Batch traceability records maintained
  • Full manufacturing documentation archived

MHRA PLPI Regulatory Filing

End-to-end MHRA Parallel Import licensing managed by our regulatory team.

  • PLPI application preparation and submission
  • Packaging and labelling compliance review
  • Patient Information Leaflet (PIL) localisation
  • MHRA correspondence and query management

Cold-Chain Logistics & Storage

Temperature-validated storage and distribution for all product categories.

  • Temperature-controlled storage (2–8°C for biologics)
  • Real-time GPS and temperature monitoring
  • Humidity and environmental condition logging
  • Qualified logistics partner network

Last-Mile & Customs Clearance

Reliable final delivery with full regulatory documentation compliance.

  • Signature-on-delivery tracking for all shipments
  • Customs brokerage and import documentation
  • Hazmat certification where required
  • Proof of delivery and receipt documentation

Pharmacovigilance & Adverse Events

Active post-market surveillance integrated with MHRA reporting requirements.

  • MHRA Yellow Card system integration
  • Adverse event monitoring and management
  • Batch recall protocols and documentation
  • On-call escalation for urgent safety signals

Regulatory Note: All products distributed by NovaPharm Healthcare are sourced exclusively from EU-GMP verified suppliers and handled under full GDP compliance. MHRA WDA(H) application is currently in progress. Full regulatory documentation is available to qualified customers on request. Contact: vishal@novapharmhealthcare.com

Infrastructure

Logistics & Compliance Infrastructure

Our supply chain infrastructure combines specialist third-party logistics partners with in-house regulatory and compliance capability — ensuring consistent quality and traceability at every point.

Cold-Chain Logistics Network

Specialist pharmaceutical cold-chain partners with temperature-sensitive distribution expertise. Real-time monitoring, validated packaging, and environmental logging ensure product integrity from origin to point of dispensing.

Global Distribution Network

Multi-territory pharmaceutical logistics capability covering Europe and the United Kingdom. Partners hold relevant pharmaceutical distribution licences, hazmat certifications, and GDP-compliant operating frameworks.

In-House Regulatory & Compliance Team

Dedicated regulatory and pharmacovigilance function with GxP-compliant systems, MHRA-integrated adverse event reporting, and batch traceability management. For pharmacovigilance enquiries: pv@novapharmhealthcare.com

Services

Supply Chain Services & Business Model

Our integrated service model delivers pharmaceutical supply chain value across multiple revenue streams — combining direct distribution, regulatory advisory, and licensing partnerships under a single operational framework.

B2B Pharmaceutical Distribution

Direct supply to NHS trusts, hospitals, independent pharmacies, and licensed wholesalers. Wholesale pricing structures with volume-based frameworks and institutional procurement support.

Licensed Medicines Portfolio

A growing portfolio of MHRA-licensed and PLPI-compliant pharmaceutical products across oral, liquid, and other dosage forms — serving a broad range of therapeutic categories.

PLPI Licensing & Regulatory

Full end-to-end MHRA PLPI application management — including documentation preparation, PIL translation and localisation, labelling compliance, and ongoing MHRA reporting obligations.

Supply Chain Solutions

Integrated cold-chain logistics, batch traceability, pharmacovigilance support, quality documentation management, and compliance audit services — available to qualified partners.

In-Licensing Partnerships

End-to-end UK market entry support for EU-GMP manufacturers — covering regulatory pathway mapping, MHRA PLPI filings, compliant packaging and labelling, and NHS distribution onboarding.

Out-Licensing Agreements

Commercial out-licensing and regional distribution agreements, structured under clearly defined contractual frameworks with agreed service levels, royalty terms, and escalation protocols.

Interested in Our Supply Chain Capabilities?

Speak with our team about supply partnerships, PLPI licensing, cold-chain logistics, or in-licensing opportunities.